Contineum Therapeutics (NASDAQ:CTNM) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Contineum Therapeutics (CTNM) operate in?

Contineum Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Contineum Therapeutics Stock (NASDAQ: CTNM) stock price, news, charts, stock research, profile.

Open	$19.05
Close	$19.64
Volume / Avg.	79.06K / 70.77K
Day Range	$18.08 - $19.64
52 Wk Range	13.27 - 22.00
Market Cap	$504.95M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	71
Short Interest	-
Days to Cover	17.33

Recent News

Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Shares of Skillsoft Corp. (NASDAQ: SKIL) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial results and issued FY25 revenue guidance below estimates.

Avi Kapoor

UnitedHealth Reports Upbeat Earnings, Joins Cullinan Oncology, Ericsson And Other Big Stocks Moving Higher On Tuesday

U.S. stocks were mostly higher, with the Dow Jones index gaining over 100 points on Tuesday.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug

Oct

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$19.05
Close	$19.64
Volume / Avg.	79.06K / 70.77K
Day Range	$18.08 - $19.64
52 Wk Range	13.27 - 22.00
Market Cap	$504.95M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	71
Short Interest	-
Days to Cover	17.33

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Contineum Therapeutics (CTNM) stock?

You can purchase shares of Contineum Therapeutics (NASDAQ:CTNM) through any online brokerage.

View our list of the best stock brokerages

Who are Contineum Therapeutics (CTNM) competitors?

Other companies in Contineum Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Third Harmonic Bio (NASDAQ:THRD), Zevra Therapeutics (NASDAQ:ZVRA), Theravance Biopharma (NASDAQ:TBPH) and GH Research (NASDAQ:GHRS).

What is the forecast, or price target, for Contineum Therapeutics (CTNM) stock?

Contineum Therapeutics has a consensus price target of $29.25.

What is the current price for Contineum Therapeutics (CTNM)?

The stock price for Contineum Therapeutics (NASDAQ: CTNM) is $19.63 last updated November 12, 2024 at 4:02 PM EST.

Does Contineum Therapeutics (CTNM) pay a dividend?

There are no upcoming dividends for Contineum Therapeutics.

When is Contineum Therapeutics (NASDAQ:CTNM) reporting earnings?

Contineum Therapeutics’s Q3 earnings are confirmed for Wednesday, November 6, 2024.

Is Contineum Therapeutics (CTNM) going to split?

There is no upcoming split for Contineum Therapeutics.

What sector and industry does Contineum Therapeutics (CTNM) operate in?

Contineum Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Comments

Contineum Therapeutics

Contineum Therapeutics (CTNM) Forecast